NO862772D0 - Fremgangsmaate ved fremstilling av legemiddelformer for oralt bruk inneholdende 9-deokso-11-deoksy-9,11-(imino(2-(2-metoksyetoksy) etyliden)-oksy)-(9s)-erytromycin. - Google Patents
Fremgangsmaate ved fremstilling av legemiddelformer for oralt bruk inneholdende 9-deokso-11-deoksy-9,11-(imino(2-(2-metoksyetoksy) etyliden)-oksy)-(9s)-erytromycin.Info
- Publication number
- NO862772D0 NO862772D0 NO862772A NO862772A NO862772D0 NO 862772 D0 NO862772 D0 NO 862772D0 NO 862772 A NO862772 A NO 862772A NO 862772 A NO862772 A NO 862772A NO 862772 D0 NO862772 D0 NO 862772D0
- Authority
- NO
- Norway
- Prior art keywords
- deoxo
- deoxy
- ethylidene
- imino
- oxy
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- -1 IMINO Chemical class 0.000 title 2
- 101000740162 Homo sapiens Sodium- and chloride-dependent transporter XTRP3 Proteins 0.000 title 1
- 102100037189 Sodium- and chloride-dependent transporter XTRP3 Human genes 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 3
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Natural products O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229960003276 erythromycin Drugs 0.000 abstract 1
- 210000004051 gastric juice Anatomy 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 125000001841 imino group Chemical group [H]N=* 0.000 abstract 1
- 239000004922 lacquer Substances 0.000 abstract 1
- 230000005923 long-lasting effect Effects 0.000 abstract 1
- 239000008188 pellet Substances 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853524572 DE3524572A1 (de) | 1985-07-10 | 1985-07-10 | Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO862772D0 true NO862772D0 (no) | 1986-07-09 |
| NO862772L NO862772L (no) | 1987-01-12 |
| NO175351B NO175351B (no) | 1994-06-27 |
| NO175351C NO175351C (no) | 1994-10-05 |
Family
ID=6275375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO862772A NO175351C (no) | 1985-07-10 | 1986-07-09 | Fremgangsmåte ved fremstilling av legemiddelformer for oral bruk inneholdende 9-deokso-11-deoksy-9,11-(imino(2-(2-metoksyetoksy) etyliden)-oksy)-(9S)-erytromycin |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4755385A (no) |
| EP (1) | EP0208971B1 (no) |
| JP (1) | JPH0688905B2 (no) |
| KR (1) | KR930010586B1 (no) |
| AT (1) | ATE63819T1 (no) |
| AU (1) | AU586262B2 (no) |
| CA (1) | CA1271138A (no) |
| DD (1) | DD248057A5 (no) |
| DE (2) | DE3524572A1 (no) |
| DK (1) | DK165670C (no) |
| ES (1) | ES2000269A6 (no) |
| FI (1) | FI85649C (no) |
| GR (1) | GR861762B (no) |
| HK (1) | HK79791A (no) |
| HU (1) | HU195730B (no) |
| IE (1) | IE58951B1 (no) |
| IL (1) | IL79375A (no) |
| MX (1) | MX9202785A (no) |
| NL (1) | NL970004I2 (no) |
| NO (1) | NO175351C (no) |
| NZ (1) | NZ216794A (no) |
| PH (1) | PH26147A (no) |
| PT (1) | PT82949B (no) |
| SG (1) | SG72191G (no) |
| ZA (1) | ZA865105B (no) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8628359D0 (en) * | 1986-11-27 | 1986-12-31 | Zyma Sa | Galenical formulation |
| US4945080A (en) * | 1987-05-26 | 1990-07-31 | Eli Lilly And Company | Dirithromycin metabolite |
| US5180589A (en) * | 1988-03-31 | 1993-01-19 | E. R. Squibb & Sons, Inc. | Pravastatin pharmaceuatical compositions having good stability |
| US5030447A (en) * | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
| IT1230576B (it) * | 1988-10-20 | 1991-10-28 | Angeli Inst Spa | Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon |
| ZA922777B (en) * | 1991-04-29 | 1993-10-15 | Lilly Co Eli | Pharmaceutical formulation containing dirithromycin |
| US5556839A (en) * | 1991-04-29 | 1996-09-17 | Eli Lilly And Company | Form II Dirithromycin |
| IT1250701B (it) * | 1991-07-24 | 1995-04-21 | Angelini Francesco Ist Ricerca | Composizione farmaceutica solida per uso orale a base di dapiprazolo |
| HU217629B (hu) * | 1991-12-12 | 2000-03-28 | Novartis Ag. | Eljárás fluvasztatint tartalmazó stabilizált gyógyszerkészítmények előállítására |
| IT1256386B (it) * | 1992-11-13 | 1995-12-04 | Luigi Boltri | Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo |
| JP4040084B2 (ja) * | 1994-02-16 | 2008-01-30 | アボツト・ラボラトリーズ | 微粒子医薬調合物の調製プロセス |
| MX9605419A (es) * | 1994-05-06 | 1997-12-31 | Pfizer | Formas de dosificacion de liberacion controlada de azitromicina. |
| US5853787A (en) * | 1995-12-22 | 1998-12-29 | Tamer International | Method for reducing coffee acidity |
| US6045843A (en) * | 1995-12-22 | 2000-04-04 | Tamer International, Inc. | Acid-reduced, whole bean coffee process |
| US6495180B1 (en) | 1995-12-22 | 2002-12-17 | Tamer International, Ltd. | Acid reduced whole bean coffee and process |
| US6066342A (en) * | 1995-12-22 | 2000-05-23 | Tamer International, Ltd. | Antacid composition |
| BE1011045A3 (fr) * | 1997-03-14 | 1999-04-06 | Ucb Sa | Compositions pharmaceutiques pour la liberation controlee de substances actives. |
| US6582708B1 (en) | 2000-06-28 | 2003-06-24 | The Procter & Gamble Company | Tooth whitening substance |
| US20020018754A1 (en) * | 1999-03-15 | 2002-02-14 | Paul Albert Sagel | Shapes for tooth whitening strips |
| US6096328A (en) | 1997-06-06 | 2000-08-01 | The Procter & Gamble Company | Delivery system for an oral care substance using a strip of material having low flexural stiffness |
| PT1187601E (pt) * | 1999-06-07 | 2005-11-30 | Altana Pharma Ag | Nova forma de preparacao e a administracao compreendendo um inibidor da bomba de protoes instavel em meio acido |
| DE19925710C2 (de) * | 1999-06-07 | 2002-10-10 | Byk Gulden Lomberg Chem Fab | Neue Zubereitung und Darreichungsform enthaltend einen säurelabilen Protonenpumpenhemmer |
| USRE42126E1 (en) | 1999-07-02 | 2011-02-08 | The Procter & Gamble Company | Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip |
| EP1118321A1 (fr) * | 2000-01-14 | 2001-07-25 | Ucb, S.A. | Compositions pharmaceutiques solides pour la libération contrôlée de substances actives |
| US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
| US6565882B2 (en) | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
| US6242003B1 (en) | 2000-04-13 | 2001-06-05 | Novartis Ag | Organic compounds |
| MXPA03000082A (es) * | 2000-06-28 | 2004-07-08 | Procter & Gamble | Estructuras y composiciones que aumentan la estabilidad de los ingredientes activos de peroxido. |
| US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
| US6541014B2 (en) | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
| US20060127474A1 (en) * | 2001-04-11 | 2006-06-15 | Oskar Kalb | Pharmaceutical compositions comprising fluvastatin |
| US6949240B2 (en) * | 2002-05-23 | 2005-09-27 | The Procter & Gamble Company | Tooth whitening products |
| US8524200B2 (en) | 2002-09-11 | 2013-09-03 | The Procter & Gamble Company | Tooth whitening products |
| AU2004258953B2 (en) | 2003-07-21 | 2011-02-10 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
| AU2004258949B2 (en) | 2003-07-21 | 2011-02-10 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
| AU2004258944B2 (en) | 2003-07-21 | 2011-02-10 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
| AU2004264939A1 (en) | 2003-08-11 | 2005-02-24 | Middlebrook Pharmaceuticals, Inc. | Robust pellet |
| CA2535398C (en) | 2003-08-12 | 2013-11-12 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
| CA2535780A1 (en) | 2003-08-29 | 2005-03-17 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
| AU2004273830B2 (en) | 2003-09-15 | 2011-03-24 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
| EP1771158A4 (en) | 2004-07-02 | 2008-03-12 | Advancis Pharmaceutical Corp | TABLET FOR PULSED DELIVERY |
| US9205054B2 (en) | 2005-03-22 | 2015-12-08 | Losan Pharma Gmbh | Solubilized ibuprofen |
| EP1916995B2 (en) * | 2005-07-29 | 2022-06-29 | Stichting Groningen Centre for Drug Research | Ph-controlled pulsatile delivery system, methods for preparation and use thereof |
| JP2009515993A (ja) * | 2005-11-17 | 2009-04-16 | ノバルティス アクチエンゲゼルシャフト | 医薬組成物 |
| US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
| US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
| TW200800233A (en) * | 2006-04-28 | 2008-01-01 | Shionogi & Amp Co Ltd | A coated preparation of macrolide antibiotics |
| US8299052B2 (en) * | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
| US10285915B2 (en) | 2012-10-17 | 2019-05-14 | The Procter & Gamble Company | Strip for the delivery of an oral care active and methods for applying oral care actives |
| GB2533593A (en) * | 2014-12-22 | 2016-06-29 | Parkside Flexibles (Europe) Ltd | Package |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3081233A (en) * | 1960-08-08 | 1963-03-12 | Upjohn Co | Enteric-coated pilules |
| US4000254A (en) * | 1966-04-25 | 1976-12-28 | Schmid Laboratories, Inc. | Fungimycin compositions |
| US3784683A (en) * | 1971-03-29 | 1974-01-08 | Abbott Lab | Tablet preparation |
| US3865935A (en) * | 1972-08-10 | 1975-02-11 | Abbott Lab | Tableting of erythromycin base |
| US3891755A (en) * | 1973-07-11 | 1975-06-24 | Abbott Lab | Dosage formulation for erythromycin cetyl sulfate |
| AT342770B (de) * | 1975-04-07 | 1978-04-25 | Thomae Gmbh Dr K | Verfahren zur herstellung neuer erythromycinderivate |
| US4127647A (en) * | 1975-04-08 | 1978-11-28 | Meiji Seika Kaisha, Ltd. | Process for preparation of stable amorphous macrolide antibiotic solids |
| JPS5840529B2 (ja) * | 1975-09-29 | 1983-09-06 | 明治製菓株式会社 | ケイコウヨウセイザイノセイホウ |
| US4289751A (en) * | 1979-06-29 | 1981-09-15 | Merck & Co., Inc. | Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof |
| US4340582A (en) * | 1981-01-15 | 1982-07-20 | Abbott Laboratories | Erythromycin base tablets |
| JPS59104326A (ja) * | 1982-12-04 | 1984-06-16 | Toyo Jozo Co Ltd | マクロライド抗生物質の安定な経口用製剤および安定化法 |
-
1985
- 1985-07-10 DE DE19853524572 patent/DE3524572A1/de not_active Withdrawn
-
1986
- 1986-06-27 DE DE8686108791T patent/DE3679463D1/de not_active Expired - Lifetime
- 1986-06-27 EP EP86108791A patent/EP0208971B1/de not_active Expired - Lifetime
- 1986-06-27 AT AT86108791T patent/ATE63819T1/de active
- 1986-07-07 GR GR861762A patent/GR861762B/el unknown
- 1986-07-08 CA CA000513268A patent/CA1271138A/en not_active Expired - Lifetime
- 1986-07-08 DK DK324786A patent/DK165670C/da not_active IP Right Cessation
- 1986-07-08 KR KR1019860005492A patent/KR930010586B1/ko not_active IP Right Cessation
- 1986-07-08 DD DD86292273A patent/DD248057A5/de not_active IP Right Cessation
- 1986-07-08 US US06/882,999 patent/US4755385A/en not_active Expired - Lifetime
- 1986-07-09 HU HU862853A patent/HU195730B/hu unknown
- 1986-07-09 NO NO862772A patent/NO175351C/no not_active IP Right Cessation
- 1986-07-09 ZA ZA865105A patent/ZA865105B/xx unknown
- 1986-07-09 JP JP61159913A patent/JPH0688905B2/ja not_active Expired - Lifetime
- 1986-07-09 IL IL79375A patent/IL79375A/xx not_active IP Right Cessation
- 1986-07-09 NZ NZ216794A patent/NZ216794A/xx unknown
- 1986-07-09 AU AU59876/86A patent/AU586262B2/en not_active Expired
- 1986-07-09 ES ES8600197A patent/ES2000269A6/es not_active Expired
- 1986-07-09 IE IE184286A patent/IE58951B1/en not_active IP Right Cessation
- 1986-07-09 PT PT82949A patent/PT82949B/pt unknown
- 1986-07-10 FI FI862898A patent/FI85649C/fi not_active IP Right Cessation
- 1986-07-11 PH PH34006A patent/PH26147A/en unknown
-
1991
- 1991-08-26 SG SG721/91A patent/SG72191G/en unknown
- 1991-10-10 HK HK797/91A patent/HK79791A/xx not_active IP Right Cessation
-
1992
- 1992-06-11 MX MX9202785A patent/MX9202785A/es unknown
-
1997
- 1997-01-31 NL NL970004C patent/NL970004I2/nl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO862772D0 (no) | Fremgangsmaate ved fremstilling av legemiddelformer for oralt bruk inneholdende 9-deokso-11-deoksy-9,11-(imino(2-(2-metoksyetoksy) etyliden)-oksy)-(9s)-erytromycin. | |
| HUT51617A (en) | Process for producing oxadiazole derivatives and pharmaceutical preparations containing these compounds as active substance | |
| HU906341D0 (en) | Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance | |
| ZA888734B (en) | Stabilized medicinal substances,a process for the preparation thereof,and stable medicinal formulations | |
| IL77186A0 (en) | Pharmaceutical insulin composition | |
| HUT58511A (en) | Process for producing pharmaceutical compositions comprising toremifen and its metabolites, suitable for ceasing the simultaneous resistance of cancer cells to several cytotoxic active ingredients | |
| SE8504945L (sv) | Farmaceutiska kompositioner innehallande antracyklinglykosider | |
| RU93036959A (ru) | Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства | |
| HUT51620A (en) | Process for producing multicyclic pyrimidine derivatives and pharmaceutical preparations containing these compounds as active substance | |
| EP0177342A3 (en) | Oral formulation of therapeutic proteins | |
| EP0341209A3 (en) | Physiologically active substances, a process for preparation and pharmaceutical compositions thereof | |
| CS8804389A2 (en) | Method of pharmaceutical preparation formulation with laminar structure for transdermal administration of active substance with null kinetic order | |
| RU98104701A (ru) | Соли висмута антибиотиков группы моеномицина, способ их получения, их применение и содержащие такие соли лекарственные средства | |
| GR890100833A (en) | Process for the preparation of a compound with gastric inhibitopy effect | |
| AU578766B2 (en) | 1,3,4-Thiadiazole derivatives, processes for their preparation, and pharmaceutical preparations containing these compounds | |
| IL83495A0 (en) | Oxirane pseudooligosaccharides,a process for their preparation,and pharmaceutical preparations containing them | |
| HU896031D0 (en) | Process for the preparation of pharmaceutical composition containing therapeutical active tetrahydronapthalene derivatives | |
| IT1238205B (it) | Forma di somministrazione orale del fosfato di creatina e relative composizioni farmaceutiche. | |
| IL81926A0 (en) | Pharmaceutical compositions for the oral administration of active proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |